(IRON) Disc Medicine - Performance 14% in 12m
IRON performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-54.59%
#79 in Peer-Group
Rel. Strength
59.31%
#3018 in Stock-Universe
Total Return 12m
13.97%
#54 in Peer-Group
Total Return 5y
-82.86%
#94 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 67.47 USD |
| 52 Week Low | 34.28 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 68.31 |
| Buy/Sell Signal +-5 | -1.32 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IRON (14%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IRON vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IRON
| Total Return (including Dividends) | IRON | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 10.96% | 2.09% | 4.55% |
| 3 Months | 6.69% | 2.27% | 10.78% |
| 12 Months | 13.97% | -10.84% | 14.71% |
| 5 Years | -82.86% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | IRON | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 81.2% | 18.8% | 79.2% |
| 3 Months | 77% | 71.5% | 92.9% |
| 12 Months | 13.8% | -84.3% | 44.2% |
| 5 Years | -53.7% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.00 | 8.69% | 6.13% |
| 3 Month | %th55.50 | 4.33% | -3.69% |
| 12 Month | %th73.50 | 27.82% | -0.65% |
| 5 Years | %th55.00 | -77.41% | -91.28% |
FAQs
Does Disc Medicine (IRON) outperform the market?
Yes,
over the last 12 months IRON made 13.97%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months IRON made 6.69%, while XBI made 2.27%.
Performance Comparison IRON vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IRON vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.5% | 6.4% | -22.5% | -1% |
| US NASDAQ 100 | QQQ | -1.3% | 5.4% | -24.7% | -1% |
| German DAX 40 | DAX | -0.3% | 11% | -35.5% | -16% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.1% | 6.8% | -20.5% | -4% |
| Hongkong Hang Seng | HSI | -0% | 5.2% | -38.3% | -22% |
| India NIFTY 50 | INDA | -0% | 8.9% | -22.3% | 14% |
| Brasil Bovespa | EWZ | -1.8% | 3.2% | -47% | 1% |
IRON vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2% | 4.2% | -29.2% | -15% |
| Consumer Discretionary | XLY | 1.1% | 9.3% | -13.8% | -6% |
| Consumer Staples | XLP | 3% | 12.6% | -20.7% | 5% |
| Energy | XLE | 3.9% | 7.5% | -17.1% | 18% |
| Financial | XLF | -0.6% | 7.9% | -25.6% | -15% |
| Health Care | XLV | 0.5% | 8.9% | -15.3% | 19% |
| Industrial | XLI | -0.1% | 7.2% | -29.1% | -10% |
| Materials | XLB | 1.5% | 9.3% | -21.9% | 11% |
| Real Estate | XLRE | 4% | 11% | -19.9% | 1% |
| Technology | XLK | -1.8% | 2.1% | -25.8% | 2% |
| Utilities | XLU | 2% | 10.9% | -25.9% | -10% |
| Aerospace & Defense | XAR | -2.4% | 1.1% | -43.9% | -39% |
| Biotech | XBI | 1.7% | 8.9% | -8.6% | 25% |
| Homebuilder | XHB | 1.3% | 4.9% | -11.3% | 13% |
| Retail | XRT | 2.6% | 9.6% | -13.8% | 8% |
IRON vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.8% | 5.84% | -13.2% | 24% |
| Natural Gas | UNG | 11.7% | 20.4% | -7.4% | 22% |
| Gold | GLD | 4.5% | 13.2% | -42.4% | -27% |
| Silver | SLV | 2.9% | 7.1% | -41.1% | -8% |
| Copper | CPER | -0.8% | 6.8% | -42.2% | -1% |
IRON vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.8% | 7.3% | -19.3% | 12% |
| iShares High Yield Corp. Bond | HYG | 1.6% | 9.1% | -21.5% | 3% |